Frequency
Latest
IMCL
Headlines
GenVec's shares sank Wednesday despite what the company said was a positive update on its experimental pancreatic cancer drug TNFerad.
1:40PM 11/19/08
Marek Fuchs pontificates about why there were two sets of bad earnings-good earnings headlines about Lilly -- from the same news sources.
09:41AM 10/24/08
Research Director Stephanie Link details the newest trade in the Action Alerts Plus Portfolio. Pharmaceuticals aren't sexy, but they will make you money, she says.
02:59PM 10/18/08
Research Director Stephanie Link details the newest trade in the Action Alert Plus Portfolio. Pharmaceuticals aren't sexy, but they will make you money, she says.
11:59AM 10/16/08
The company launches its bid to take over ImClone.
4:14PM 10/14/08
The $70-a-share offer represents a 51% premium to ImClone's closing stock price July 31, when a Bristol-Myers' offer came to light.
9:59AM 10/14/08
Smaller companies could learn a lot from Big Pharma's constant focus on the future.
11:50AM 10/10/08
King Pharmaceuticals bucks an otherwise dismal day in health stocks.
5:27PM 10/09/08
Genentech shares drop on investor concerns about financing for the company's deal with Roche but ease off their lows by the closing bell.
5:19PM 10/08/08
The Dow, which sank as much as 800 points earlier, stages a late-day rally to end the session down 3.6%. Frank Curzio breaks down the action in The Real Story video (above).
4:34PM 10/06/08
Understanding the Market
Our Experts' Take at RealMoney for Imclone Systems Inc.
Companies with cash stockpiles are sitting on huge opportunities to add value.
4:00PM 12/02/08
Stocks went down too far yesterday, and they're probably bouncing too high today.
1:34PM 12/02/08
More Experts' Takes on IMCL
More popular tickers are indicated by scale.
